Dermata Therapeutics, Inc. (DRMA)

Dermata Therapeutics Statistics

Total Valuation

DRMA has a market cap or net worth of $1.84 million. The enterprise value is -$3.11 million.

Market Cap	1.84M
Enterprise Value	-3.11M

Important Dates

The next estimated earnings date is Friday, November 15, 2024, after market close.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

DRMA has 1.51 million shares outstanding. The number of shares has increased by 373.37% in one year.

Shares Outstanding	1.51M
Shares Change (YoY)	+373.37%
Shares Change (QoQ)	+52.36%
Owned by Insiders (%)	0.96%
Owned by Institutions (%)	2.22%
Float	1.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.25
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.73

Current Ratio	2.73
Quick Ratio	2.58
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -173.01% and return on invested capital (ROIC) is -111.46%.

Return on Equity (ROE)	-173.01%
Return on Assets (ROA)	-90.68%
Return on Capital (ROIC)	-111.46%
Revenue Per Employee	n/a
Profits Per Employee	-$1.23M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -90.10% in the last 52 weeks. The beta is 0.79, so DRMA's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-90.10%
50-Day Moving Average	1.55
200-Day Moving Average	3.76
Relative Strength Index (RSI)	37.52
Average Volume (20 Days)	190,509

Short Selling Information

The latest short interest is 28,506, so 1.89% of the outstanding shares have been sold short.

Short Interest	28,506
Short Previous Month	69,108
Short % of Shares Out	1.89%
Short % of Float	1.91%
Short Ratio (days to cover)	0.02

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.12M
Pretax Income	-9.82M
Net Income	-9.82M
EBITDA	n/a
EBIT	-10.12M
Earnings Per Share (EPS)	-$23.74

Balance Sheet

Cash & Cash Equivalents	4.95M
Total Debt	n/a
Net Cash	4.95M
Net Cash Per Share	$3.28
Equity (Book Value)	3.32M
Book Value Per Share	4.79
Working Capital	3.32M

Cash Flow

Operating Cash Flow	-7.75M
Capital Expenditures	n/a
Free Cash Flow	-7.75M
FCF Per Share	-$5.13

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DRMA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-373.37%
Shareholder Yield	-373.37%
Earnings Yield	-533.63%
FCF Yield	-421.26%

Analyst Forecast

The average price target for DRMA is $6.00, which is 392.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	392.57%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on May 16, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	May 16, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1